Page 65 - ESHRE2019
P. 65

 Clinical pregnancy rate
                         Menevit Mg
VitE
Zinc N‐Ac‐Cys
Zinc + folic acid Folic acid
        5.9%
OD=3.43 [1.92‐6.11]
 16.6%
  Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gynaecol. 2007 Jun;47(3):216-21.
Antioxidant: 38.5% ongoing pregnancy at 13 weeks Placebo : 16% ongoing pregnancy at 13 weeks
  59
 PRECONGRESS COURSE 01 I VIENNA, AUSTRIA – 23 JUNE 2019 63
   






















































































   63   64   65   66   67